FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance

FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance

FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance
By utilizing technology, such as telemedicine, to deliver consent and … When using digital health technologies, sponsors and investigators …

See more –> Source

Follow us on Twitter and TikTok